Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2013
11/28/2013US20130317029 Oxypyrimidines as syk modulators
11/28/2013US20130317028 C5aR ANTAGONISTS
11/28/2013US20130317027 Compounds and therapeutic uses thereof
11/28/2013US20130317026 Substituted 6,5-fused bicyclic heteroaryl compounds
11/28/2013US20130317010 Tetrahydroisoquinoline derivative
11/28/2013US20130317008 Use of a Specific Cyclic Amine Derivative or the Pharmaceutically Acceptable Salts Thereof for the Treatment or Prevention of Heart Failure
11/28/2013US20130317003 Histone Deacetylase Inhibitors
11/28/2013US20130316981 Tertiary amines, medicaments containing said amines, use thereof and processes for the preparation thereof
11/28/2013US20130315895 COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET
11/28/2013CA2875990A1 Heterocyclyl pyrimidine analogues as tyk2 inhibitors
11/27/2013EP2666768A2 Condensed-cyclic compound and organic light-emitting diode comprising the same
11/27/2013EP2665726A2 Compositions and methods for cardiovascular disease
11/27/2013EP2665711A1 Picolinamide inhibitors of kinases
11/27/2013EP2665709A1 Diarylacetylene hydrazide containing tyrosine kinase inhibitors
11/27/2013EP2665706A1 Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer
11/27/2013CN103415514A Method for producing phenoxypyridine derivative
11/27/2013CN103415507A 3-amino-pyridines as GPBAR1 agonists
11/27/2013CN103415289A Pro-neurogenic compounds
11/27/2013CN103408533A Novel substituted pyridin-2-ones and pyridazin-3-ones
11/27/2013CN103408532A Preparation method for proton pump inhibitor
11/27/2013CN103408502A Synthetic method of quinazolinone compounds
11/27/2013CN103408482A Phenyl spiro-oxime-ether enol ester compounds and applications thereof
11/27/2013CN103405431A Opioid and opioid-like compounds and uses thereof
11/27/2013CN102574837B Novel 5-fluorouracil derivative
11/27/2013CN102421754B Acrylamide derivative and use thereof in manufacture of medicament
11/27/2013CN102391168B Symmetrical difunctional coupling agent and coupled molecular imaging agents thereof
11/27/2013CN102285965B N-(cyanoalkyl) benzamide compound and application thereof
11/27/2013CN102285964B Cyanobenzamide compound and application thereof
11/27/2013CN102216283B Quinazoline derivatives as NK3 receptor antagonists
11/27/2013CN102212057B Carboxylic acid non-steroidal anti-inflammatory agent derivative and preparation method and application thereof
11/27/2013CN101977900B 5-fluoro pyrimidine derivatives
11/27/2013CN101918362B 吡啶衍生物 Pyridine derivatives
11/27/2013CN101857588B 4-aromatic aminoquinazoline derivative and purpose thereof
11/27/2013CN101809012B Spiro substituted compounds as angiogenesis inhibitors
11/27/2013CN101765591B Pyrimidine derivatives useful for treatment of inflammatory or allergic conditions
11/27/2013CN101163478B Compounds for inflammation and immune-related uses
11/26/2013US8592601 Precursor phase and use thereof for preparing the magnesium tetrahydrate salt of an omeprazole enantiomer
11/26/2013US8592600 Solid state forms of racemic ilaprazole
11/26/2013US8592599 Solid state forms of racemic ilaprazole
11/26/2013US8592598 Method of producing a crystal of an imidazole compound
11/26/2013US8592597 Pyrrole compounds
11/26/2013US8592591 Fused bicyclic imidazoles
11/26/2013US8592588 Process to prepare camptothecin derivatives
11/26/2013US8592584 Compositions and methods including cell death inducers and procaspase activation
11/26/2013US8592583 Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1H-pyrrole-3-carboxamides
11/26/2013US8592580 Substituted triazinone derivatives
11/26/2013US8592579 Pyrrolotriazine kinase inhibitors
11/26/2013US8592459 Substituted benzimidazoles and methods of their use
11/26/2013US8592458 Alpha7 nicotinic receptor selective ligands
11/26/2013US8592456 IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation
11/26/2013US8592455 Kinase inhibitors and methods of their use
11/26/2013US8592444 Spirocyclic derivatives as histone deacetylase inhibitors
11/26/2013US8592441 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
11/26/2013US8592427 Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
11/26/2013US8592416 Isoquinolin-1 (2H)-one derivatives as PARP-1 inhibitors
11/26/2013US8592383 Cycloalkyl-fused tetrahydroquinolines as CRTH2 receptor modulators
11/26/2013US8592056 Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative
11/26/2013CA2585615C Dicarboxamide derivatives and their use as factor xa inhibitors
11/26/2013CA2335240C Cyanine dyes and synthesis methods thereof
11/22/2013CA2788470A1 Novel ni complex and its derivatives, producing method, and the use thereof as antioxidant
11/21/2013WO2013173392A1 Drug-conjugates, conjugation methods, and uses thereof
11/21/2013WO2013173382A1 Benzothiophene sulfonamides and other compounds that interact with glucokinase regulatory protein
11/21/2013WO2013173218A1 1,3-diaryl-substituted heterocyclic pesticides
11/21/2013WO2013173198A1 Pyrimidinylpiperidinyloxypyridone analogues as gpr119 modulators
11/21/2013WO2013172872A1 Pyrimidine diamine derivatives as inhibitors of cytosolic hsp90
11/21/2013WO2013172835A1 Biscarbazole derivative host materials for oled emissive region
11/21/2013WO2013172255A1 Compound, light emitting material, and organic light emitting element
11/21/2013WO2013172169A1 Heterocyclic compound, metal complex catalyst and use of same
11/21/2013WO2013171642A1 Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013WO2013171641A1 Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013WO2013171640A1 Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013WO2013171639A1 Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013WO2013171470A1 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof
11/21/2013WO2013171318A1 Benzo[1,3]dioxine derivatives and their use as lpar5 antagonists
11/21/2013WO2013171281A1 Hydantoin and thiohydantoin derivatives as antiviral drugs
11/21/2013WO2013170758A1 Fused ring-structured benzamide compound and application thereof as antineoplastic medicament
11/21/2013WO2013170671A1 Pteridine ketone derivative and applications thereof as egfr, blk, and flt3 inhibitor
11/21/2013WO2013032558A4 Products for anti-inflammation support
11/21/2013WO2012125438A8 Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
11/21/2013US20130310567 Method for preparing 2-aminobenzamide derivatives
11/21/2013US20130310566 Organic amine dimmer and method for synthesizing the same
11/21/2013US20130310565 Novel nitrogen-containing heteroaryl compounds and methods of use thereof
11/21/2013US20130310557 Amorphous Besifloxacin Solid
11/21/2013US20130310419 Pyrrole derivatives used as modulators of alpha7 nachr
11/21/2013US20130310400 Spiro aminic compounds with nk1 antagonist activity
11/21/2013US20130310399 Chemical compounds
11/21/2013US20130310395 Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013US20130310393 Substituted benzimidazole and imidazopyridine compounds useful as cyp17 modulators
11/21/2013US20130310388 Modulators of TNF-Alpha Signaling
11/21/2013US20130310379 Modulators of methyl modifying enzymes, compositions and uses thereof
11/21/2013US20130310378 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
11/21/2013US20130310377 Novel modulators of calcium release-activated calcium channel
11/21/2013US20130310375 N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
11/21/2013US20130310373 Pyrimidine compound
11/21/2013US20130310365 Cyclohexyl-azetidinyl antagonists of ccr2
11/21/2013US20130310361 Compounds and compositions as kinase inhibitors
11/21/2013US20130310358 Pyrimidine compounds as delta opioid receptor modulators
11/21/2013US20130310357 Azolyl Urea Compounds and Methods of Use Thereof
11/21/2013US20130310348 Quinoline derivatives and uses thereof
11/21/2013US20130310320 Boronic ester and acid compounds, synthesis and uses
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 1080